Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug;24(4):249-251.
doi: 10.1016/j.jaapos.2020.04.006. Epub 2020 Jul 2.

Ocular manifestations of mycoplasma-induced rash and mucositis

Haoxing D Jin  1 , R Michael Siatkowski  2 , Rhea L Siatkowski  2
Affiliations
Case Reports

Ocular manifestations of mycoplasma-induced rash and mucositis

Haoxing D Jin et al. J AAPOS. 2020 Aug.

Abstract

A 13-year-old girl presented with a 5-day history of fever and cough followed by new-onset oral ulcers and conjunctival injection. Clinical examination revealed bilateral 360-degree subconjunctival hemorrhages, which later evolved to corneal epithelial defects, pseudo-membrane formation, and extensive oral mucosal ulceration. Mycoplasma pneumoniae serum IgG and IgM were positive. Treatment with topical prednisolone acetate, moxifloxacin, preservative-free artificial tears, and erythromycin ointment was initiated. A self-retaining amniotic membrane was placed. The ocular and oral lesions resolved within 2 weeks of treatment, and the patient's vision returned to baseline. Mycoplasma-induced rash and mucositis is a newly defined entity that mainly affects children and has a favorable prognosis with early detection and treatment.

PubMed Disclaimer

Figures

Fig 1
Fig 1
External photographs showing bilateral conjunctival injection (A) and oral ulceration (B) during initial hospitalization.
See this image and copyright information in PMC

References

    1. Gordon O., Oster Y., Michael-Gayego A. The clinical presentation of pediatric mycoplasma pneumoniae infections-A single center cohort. Pediatr Infect Dis J. 2019;38:698–705. - PubMed
    1. Canavan T.N., Mathes E.F., Frieden I., Shinkai K. Mycoplasma pneumoniae–induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72:239–245. - PubMed
    1. Sekula P., Dunant A., Mockenhaupt M. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133:1197–1204. - PubMed
    1. Bastuji-Garin S., Rzany B., Stern R.S., Shear N.H., Naldi L., Roujeau J.C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92–96. - PubMed
    1. Vujic I., Shroff A., Grzelka M. Mycoplasma pneumoniae-associated mucositis—case report and systematic review of literature. J Eur Acad Dermatol Venereol. 2015;29:595–598. - PubMed

Publication types